ASH 2023 Post Conference Perspectives: Highlights in Multiple Myeloma
Rafael Fonseca, MD, discusses findings from the PERSEUS trial presented in December at ASH 2023.
A medical expert navigates the treatment landscape for patients newly diagnosed with multiple myeloma.
The IsKia trial findings presented at ASH 2023 are highlighted by Dr Fonseca.
The MonumenTAL-2 study is discussed by Rafael Fonesca, MD.
A key opinion leader explores the integration of bispecifics into MM therapy regimens.
Dr Fonesca highlights key factors in multiple myeloma treatment affecting patient quality of life.
Dr Fonesca provides his final thoughts recapping data and findings presented at ASH 2023.
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
3
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
4
ICER Draft Flags High Cost of New Hypertension Drug Class
5